2015 ASH Annual Meeting

CML

Prediction for deeper molecular response after TKI treatment in CML patients No ratings yet.

Dennis Kim, MD, FRCP(c)
Associate Professor, Faculty of Medicine
University of Toronto
Toronto, Ontario, Canada
MPN

Combination therapy for patients with MPN No ratings yet.

Vikas Gupta, MD, FRCPC, FRCPath
Associate Professor
Department of Medicine
University of Toronto
Cancer Clinical Research Unit (CCRU)
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
AML

Induction and consolidation No ratings yet.

Karen Yee, MD, FRCPC
Cancer Clinic Research Unit
Princess Margaret Cancer Centre
University Health Network
Toronto, Ontario, Canada
MPN

Predictive values of next generation sequencing (NGS) in myeloproliferative neoplasms (MPNS) No ratings yet.

Christopher Hillis, MD, FRCPC
Juravinski Hospital and Cancer Centre
Hamilton, Ontario, Canada
MPN

Long-term efficacy of pegylated Interferon in ET and PV No ratings yet.

Shireen Sirhan
MD, FRCPC
Hematologist and Medical Oncologist
Montreal Jewish General Hospital
MPN

Pacritinib in myelofibrosis: Subgroup analysis of PERSIST-1 No ratings yet.

Shireen Sirhan
MD, FRCPC
Hematologist and Medical Oncologist
Montreal Jewish General Hospital
MPN

Long-term efficacy of PRM-151 in myelofibrosis No ratings yet.

Shireen Sirhan
MD, FRCPC
Hematologist and Medical Oncologist
Montreal Jewish General Hospital